In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Agouron announces trial of anti-angiogenesis drug
Immune Response receives two U.S. patents
Immune Response announces restructuring of license agreement
Immune Response Corporation not to proceed with HIV study
Immune Response licenses Hybridon's 2nd-generation CpG DNA adjuvant
PPD Discovery and Agouron announce genomics alliance
Agouron acquires Rescriptor from Pharmacia & Upjohn